Okogen to receive over $10mn from MRCF through Series A funding
Date: 2018-03-01   Author: Saipriya Iyer  Category: #market

Okogen to receive over $10mn from MRCF through Series A funding

Brandon Capital’s Medical Research Commercialization Fund (MRCF), one of the biggest life science investment fund firms in New Zealand & Australia, has reportedly made investments worth USD 10 million in Okogen Inc., a biotech firm developing ophthalmic anti-effective medicines, in its Series A funding. As per sources, the funds are expected to assist Okogen in developing OKG 0301, a leading candidate for viral conjunctivitis.

For the uninitiated, adenoviral conjunctivitis is one of the main causes of eye infection across the globe. With no approved treatments, unmet medical needs of patients are rampant across the globe. Researchers have been testing the ability of OKG-0301, an effective ribonuclease with proven antiviral characteristics, to treat viral conjunctivitis in the patients by conducting Phase 2 clinical trials before 2018.

Incidentally, OKG-0301 is currently undergoing clinical development, and with MRCF’s funds, the commencement of the Phase II clinical trial for OKG-0301 will be onboard in 2018. As per reports, nearly 30 million cases of acute conjunctivitis occur yearly across the globe, which includes approximately 6 million of the U.S. population. Around 70% of the U.S. population is treated for acute conjunctivitis every year, and 80% of these patients are diagnosed with viral forms of the infection.

The CEO of Okogen Inc., has announced that safe & effective therapies are required to treat highly infectious ailments such as conjunctivitis and OKG-0301 has the clinical & commercial potential to treat the same. He further added that the Series A funding by Brandon Capital will help the firm in exploring new opportunities across the biopharmaceutical sector.

MRCF’s Investment Manager has also reaffirmed his faith in Okogen by stating that the funding will help in making Okogen’s technology stronger and equip the same with the potential of bringing a positive change in the lives of many patients.



About Author


Saipriya Iyer

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

More from Saipriya


Post Recommendents

Worldwide Biotechnology Reagents Market Forecast 2020-2025 Growth Drivers, Regional Outlook
Author: Ashwin Naphade

Market Study Report, LLC, has added an exhaustive research study of the ' Biotechnology Reagents market', detailing every single market driver and intricately analyzing the business vertical. This ' Biotechnology Reagents market' s...


2025 Projections: Four Wheel Drive Vehicles Market Report by Type, Application and Regional Outlook
Author: Ashwin Naphade

The ' Four Wheel Drive Vehicles market' report added recently by Market Study Report, LLC, evaluates the industry in terms of market size, market share, revenue estimation, and geographical outlook. The study also delivers a precise summar...


Worldwide Potassium Citrate Market Study for 2020 to 2025 providing information on Key Players, Growth Drivers and Industry challenges
Author: Ashwin Naphade

The ' Potassium Citrate market' report Added by Market Study Report, LLC, enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive ...